Feature | July 26, 2013

Healthcare Decision Support and IBM Watson — Market Shares, Strategies, Forecasts

July 26, 2013 — Worldwide healthcare cognitive computing markets are poised to achieve continuing growth as the healthcare delivery system responds to new products. Growth is achieved in response to changing technology, better analytics, new information systems that leverage natural language and changing market conditions.

Healthcare decision support markets consist of traditional market participants led by McKesson and Watson from IBM. IBM Watson offers structured and unstructured data in combination. This represents a major breakthrough in what kind of decision support can be offered.

IBM Watson can provide a far more differentiated testing assessment and knows what tests are relevant to further characterize a particular patient condition and what tests are not. Having an assistant that is able to have read the latest journal articles and is loaded with medical information to recommend what tests may be relevant in a particular situation is a great help to physicians. Wrong tests, tests that are not useful in a particular situation, account for 30 percent of the costs of healthcare delivery in the United States. 

IBM Watson is initiating a new era of cognitive computing that extends the tabulator and application program intensive enabling new market opportunities based on cognitive performance. Watson is comprised of a powerful core engine. The first purpose that Watson has been put to is to improve healthcare delivery. 

For more information: www.researchandmarkets.com/research/v5ccjm/healthcare

Related Content

integrated clinical decision support, CDS, Wolters Kluwer, E-book
News | Clinical Decision Support| January 28, 2016
The Health division of Wolters Kluwer announced the release of a complimentary e-book that demonstrates the critical...

Image courtesy of Philips Healthcare

Feature | Clinical Decision Support| January 06, 2016 | Dave Fornell
Technology | Clinical Decision Support| December 22, 2015
December 22, 2015 — The American College of Cardiology (ACC) has launched a new Society of Thoracic Surgeons (STS)/AC
DataSpeaks, SRI International, license, SIMA, clinical decision support
News | Wearable Sensors| September 09, 2015
SRI International and DataSpeaks Inc. announced that SRI has licensed the Science of Individuality Measurement...
IBM, purchase, Merge Healthcare, $1 billion, Watson
News | Cardiac PACS| August 06, 2015
August 6, 2015 — IBM announced that its Watson Health Cloud will gain the ability to “see” following the planned acqu
echocardiography, ASE, hypertrophic cardiomyopathy, HCM, interpretation, Narula
News | Cardiovascular Ultrasound| June 15, 2015
A research team from New York has announced advances in automated echocardiography decision systems that could help...
CDS, clinical decision support, Rand Corp., study, appropriateness
Feature | Clinical Decision Support| June 04, 2015
Using tools that help physicians decide whether to use expensive imaging studies can help reduce the ordering of...
Stage 3 MU, stage 3meaningful use, patient engagement

Patient engagement plays a key role in the Stage 3 MU rules, where patients are more involved in their health management and treatment decisions. Part of Stage 3 requires electronic patient access to all their medical records, enabled by patient portals, as in this example of Carestream's Vue Motion software.

Feature | Information Technology| May 07, 2015 | Dave Fornell
The Centers for Medicare and Medicaid Services (CMS) gathered public comments on its Stage 3 Meaningful Use (MU)...
News | Clinical Decision Support| April 29, 2015
COR Medical Technologies (COR) announced that Gregg W. Stone, M.D. has been appointed to its Senior Editorial Board.
Overlay Init